Business Context and Reporting Period
Company: ARGENX SE
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: January 12, 2026
Reporting Period: Current report for the month of January 2026.
This filing serves to incorporate by reference a press release and an investor presentation issued by the Company on January 12, 2026. The document itself does not contain standalone financial statements or operational data but acts as a conduit for the attached exhibits.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached Exhibits 99.1 (Press Release) and 99.2 (Investor Presentation), which are not included in the provided source text.
Material Changes
No material changes regarding financial performance or operations are detailed in the body of this Form 6-K. The filing indicates that the Company has issued new communications (press release and presentation) that may contain updates, but the specific nature of these changes is not described in the filing text itself.
Guidance, Outlook, and Risks
Guidance and Outlook: The filing does not explicitly state guidance or outlook figures. Such information is presumed to be in the attached investor presentation (Exhibit 99.2).
Risks and Contingencies: No specific risks or contingencies are listed in this filing text. The document notes that the information is incorporated by reference into various Registration Statements (Forms F-3 and S-8).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 12, 2026) for the specific announcement triggering this filing.
- Examine Exhibit 99.2 (Investor Presentation dated January 12, 2026) for updated financial guidance, pipeline data, and strategic outlook.
- Verify the incorporation of this report into the Company's active Registration Statements (File Nos. 333-258251, 333-225375, 333-258253, 333-274721, and 333-292200).
- Confirm that no subsequent filings have superseded the information contained in the January 12, 2026 exhibits.